Deregulation of the cytoplasmic tyrosine kinase cSrc in the absence of a truncating mutation at codon 531 in human bladder carcinoma.
The involvement of the cytoplasmic tyrosine kinase cSrc was investigated in human bladder carcinogenesis. Kinase activity was determined in tissue lysates from bladder transitional cell carcinoma (TCC) relative to normal epithelia. Strong kinase activation was observed at all stages of carcinogenesis with a peak at the stage pT1, where tumor cells disrupt the basement membrane and invade the submucosa. In agreement with a role for cSrc in cell invasion, immunocytochemistry analysis showed a strong staining of invading cells. An increase in cSrc protein level were also found in most tumor samples, however, it did not correlate with an increase in activity (r = 0.44) suggesting that cSrc is deregulated in these tumors. Indeed, high Src activity was affinity-purified from a column (IRSVSSDGHE(p)YIYVDP-Affigel 10) that specifically retains active Src. Enzymatic regulation involves the C-terminus, recently found mutated at codon 531 in a subset of advanced human colon cancers. However, no such mutations were detected in TCC, suggesting the existence of other mechanisms for kinase activation.
Bénistant
C
C
CNRS UPR-1086, Montpellier, France.
Chapuis
H
H
Mottet
N
N
Noletti
J
J
Crapez
E
E
Bali
J P
JP
Roche
S
S
D001483:Base Sequence; D002295:Carcinoma, Transitional Cell / Q000201:enzymology* / Q000235:genetics* / Q000473:pathology; D003062:Codon / Q000235:genetics; D003593:Cytoplasm / Q000201:enzymology; D017931:DNA Primers / Q000235:genetics; D004789:Enzyme Activation; D015971:Gene Expression Regulation, Enzymologic; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D009154:Mutation; D009367:Neoplasm Staging; D001749:Urinary Bladder Neoplasms / Q000201:enzymology* / Q000235:genetics* / Q000473:pathology; D019061:src-Family Kinases / Q000235:genetics* / Q000378:metabolism*
D003062:Codon; D017931:DNA Primers; D019061:src-Family Kinases